Drug Profile
Research programme: echinacea-derived immunostimulating compounds - MolecularNature Limited
Alternative Names: Echinacea-derived bio-active compounds - MolecularNature Limited; Echinacea-derived immunostimulating compounds - MolecularNature LimitedLatest Information Update: 30 Sep 2011
Price :
$50
*
At a glance
- Originator MNLpharma
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 06 Sep 2005 Preclinical trials in Autoimmune disorders in USA (unspecified route)